• No results found

LNG-IUS

Management of primary dysmenorrhea in young women with frameless LNG-IUS

Management of primary dysmenorrhea in young women with frameless LNG-IUS

... frameless LNG-IUS, releasing 20 µg of LNG/day, was ...frameless LNG-IUS in other studies suggests that the frameless design may be preferred over a framed LNG-IUS, as the ...

6

Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-IUS

Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-IUS

... Abstract: Intrauterine devices (IUDs) provide highly effective, long-term, safe, reversible contraception, and are the most widely used reversible contraceptive method worldwide. The levonorgestrel-releasing intrauterine ...

14

Role of LNG IUS in adenomyosis in reproductive age group women: a prospective interventional study

Role of LNG IUS in adenomyosis in reproductive age group women: a prospective interventional study

... conclude, LNG-IUS is a safe, effective, reversible and acceptable mode of treatment for heavy menstrual bleeding and dysmenorrhoea in the patients of adenomyosis and can be a good alternative to ...rate. ...

6

A comparative, randomized study of levonorgestrel Intrauterine System (LNG IUS) vs Copper T 380 A intrauterine device applied during cesarean section

A comparative, randomized study of levonorgestrel Intrauterine System (LNG IUS) vs Copper T 380 A intrauterine device applied during cesarean section

... of LNG-IUS during the first year of ...favoring LNG-IUS ...in LNG- IUS group based in a major proportion of women with normal Ferritin levels, related with extremely low inci- ...

5

Levonorgestrel Intrauterine System (LNG IUS) in Menorrahgia: A Follow Up Study

Levonorgestrel Intrauterine System (LNG IUS) in Menorrahgia: A Follow Up Study

... (LNG IUS) for treatment of ...for LNG IUS underwent its ...Conclusion: LNG IUS is a less invasive, effective treatment modality for menorrahgia with reasonable ...

7

Use of mixed-treatment-comparison methods in estimating efficacy of treatments for heavy menstrual bleeding

Use of mixed-treatment-comparison methods in estimating efficacy of treatments for heavy menstrual bleeding

... for LNG-IUS and endometrial ablation [28] and somewhat lower efficacy for oral ...treatments. LNG-IUS and abla- tion, however, are designed for long-term (1 year or lon- ger) reduction of ...

9

Endometrial resection following levonorgestrel intrauterine system treatment for menorrhagia

Endometrial resection following levonorgestrel intrauterine system treatment for menorrhagia

... Table 2 shows operative details and operative complica- tions in both groups. Laparoscopic tubal ligation subse- quent to endometrial resection was performed in 18 (40%) cases using LNG-IUS and in five ...

5

Use of frameless intrauterine devices and systems in young nulliparous and adolescent women: results of a multicenter study

Use of frameless intrauterine devices and systems in young nulliparous and adolescent women: results of a multicenter study

... the stem and transverse arm of the IUD in the uterine cavity. Research can use this new technology to design new and improved IUDs. A new generation of IUDs could be developed which adapt to the width of the uterine ...

8

Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine system

Review of the safety, efficacy and patient acceptability of the levonorgestrel-releasing intrauterine system

... following LNG-IUS insertion is very low (less than 1 in 100) in women who are at low risk of STIs and removals due to PID among LNG-IUS users is below 1% at 1 year, and below ...the ...

10

Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety

Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety

... Recognizing the lack of health economic evidence on pharmaceutical treatments for HMB, the National Institute for Health and Clinical Excellence (NICE) guidelines for heavy menstrual bleeding developed a state-transition ...

9

Preventing recurrence of endometriosis by means of long-acting progestogen therapy (PRE-EMPT): report of an internal pilot, multi-arm, randomised controlled trial incorporating flexible entry design and adaption of design based on feasibility of recruitme

Preventing recurrence of endometriosis by means of long-acting progestogen therapy (PRE-EMPT): report of an internal pilot, multi-arm, randomised controlled trial incorporating flexible entry design and adaption of design based on feasibility of recruitment

... All women scheduled for surgery in the six participating centres were approached with information regarding the trial. They were provided with a Patient Information Sheet and given the opportunity to ask questions. Once ...

9

SCharm-_FINAL.pdf

SCharm-_FINAL.pdf

... late IUS insertion ...an LNG-IUs insertion 6–8 weeks postpartum were more likely to breastfeed at 6 months than those who had an IUS inserted immediately after ...

25

Levonorgestrel releasing intrauterine system vs  usual medical treatment for menorrhagia: an economic evaluation alongside a randomised controlled trial

Levonorgestrel releasing intrauterine system vs usual medical treatment for menorrhagia: an economic evaluation alongside a randomised controlled trial

... compared LNG-IUS to non-hormonal and hormonal treatments, showing reduction in menstrual blood loss but these did not consider cost-effectiveness ...

11

Contraceptive Options Following Gestational Diabetes: Current Perspectives

<p>Contraceptive Options Following Gestational Diabetes: Current Perspectives</p>

... The effects of the ENG implant on carbohydrate meta- bolism have been reported in several studies. One reported no differences in carbohydrate metabolism in implant and Cu-IUD users. Insulin and glucose, oral glucose ...

13

Satisfaction and health-related quality of life in women with heavy menstrual bleeding; results from a non-interventional trial of the levonorgestrel-releasing intrauterine system or conventional medical therapy

Satisfaction and health-related quality of life in women with heavy menstrual bleeding; results from a non-interventional trial of the levonorgestrel-releasing intrauterine system or conventional medical therapy

... Three countries (Pakistan, South Korea, and the People’s Republic of China) contributed approximately 80% of the recruited patients. All patients were included in the safety analysis (full analysis set), while the ...

8

Intrauterine levonorgestrel delivery with frameless fibrous delivery system: review of clinical experience

Intrauterine levonorgestrel delivery with frameless fibrous delivery system: review of clinical experience

... Assessing uterine fundal thickness by ultrasound will help physicians, unfamiliar with the procedure, to gain experi- ence in providing a safe and adequate insertion. Typically, the fundal wall should be at least 10 mm. ...

10

Treatment of heavy menstrual bleeding associated with uterine leiomyoma with the levonorgestrel-releasing intrauterine system

Treatment of heavy menstrual bleeding associated with uterine leiomyoma with the levonorgestrel-releasing intrauterine system

... in LNG-IUS ...of LNG-IUS in ten women of fertile age, did not find any change in the uterine pulsatility index ...the LNG-IUS ...

7

A randomized clinical trial to compare levonorgestrel-releasing intrauterine system (Mirena) vs trans-cervical endometrial resection for treatment of menorrhagia

A randomized clinical trial to compare levonorgestrel-releasing intrauterine system (Mirena) vs trans-cervical endometrial resection for treatment of menorrhagia

... in LNG-IUS group ...and LNG-IUS. There was comparable efficacy, although studies of LNG-IUS were generally small and consequently ...

5

Quality of Life in Women with Endometriosis Pelvic Pain Treated with the Levonorgestrel Releasing Intrauterine System

Quality of Life in Women with Endometriosis Pelvic Pain Treated with the Levonorgestrel Releasing Intrauterine System

... consultation at Obstetrics and Gynecology Hospital, who signed informed consent for participation in the study, were included. The mean age was 31.7 ± 4.7 years. Only two patients were referred with suspected diagnosis ...

6

A feedback survey on the clinical performance and acceptability of levonorgestrel releasing intrauterine system (EMILY®) during two years of usage

A feedback survey on the clinical performance and acceptability of levonorgestrel releasing intrauterine system (EMILY®) during two years of usage

... (LNG- IUS) is a small intrauterine device developed for safe, effective and acceptable reversible contraception for longer ...of LNG-IUS in the treatment of ...the LNG-IUS, ...

6

Show all 166 documents...

Related subjects